Mendelian randomization study revealed a gut microbiota-neuromuscular junction axis in myasthenia gravis

Jiaying Shi,Ming Yi,Shengyu Xie,Zhaokun Wang,Xinyue Zhang,Xiaolan Tan,Dachang Tao,Yunqiang Liu,Yuan Yang
DOI: https://doi.org/10.1038/s41598-024-52469-7
IF: 4.6
2024-01-31
Scientific Reports
Abstract:A growing number of studies have implicated that gut microbiota abundance is associated with myasthenia gravis (MG). However, the causal relationship underlying the associations is still unclear. Here, we aim to investigate the causal effect of gut microbiota on MG using Mendelian randomization (MR) method. Publicly available Genome-wide association study (GWAS) summary-level data for gut microbiota and for MG were extracted. Inverse variance weighted was used as the main method to analyze causality. The robustness of the results was validated with sensitivity analyses. Our results indicated that genetically predicted increased phylum Lentisphaerae (OR = 1.319, p = 0.026), class Lentisphaerae (OR = 1.306, p = 0.044), order Victivallales (OR = 1.306, p = 0.044), order Mollicutes (OR = 1.424, p = 0.041), and genus Faecalibacterium (OR = 1.763, p = 0.002) were potentially associated with a higher risk of MG; while phylum Actinobacteria (OR = 0.602, p = 0.0124), class Gammaproteobacteria (OR = 0.587, p = 0.036), family Defluviitaleaceae (OR = 0.695, p = 0.047), family Peptococcaceae (OR = 0.698, p = 0.029), and family Family XIII (OR = 0.614, p = 0.017) were related to a lower risk of MG. The present study provides genetic evidence for the causal associations between gut microbiota and MG, thus suggesting novel insights into the gut microbiota-neuromuscular junction axis in the pathogenesis of MG.
multidisciplinary sciences
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to explore the causal relationship between the gut microbiome and Myasthenia Gravis (MG). Specifically, the researchers use Mendelian Randomization (MR) methods to analyze large-scale Genome-Wide Association Study (GWAS) data to investigate the causal link between specific gut microbiota and the risk of MG. ### Main Findings - **Microbiota Increasing Risk**: The study found that Lentisphaerae at the phylum level (Odds Ratio [OR] = 1.319, p = 0.026), Lentisphaerae at the class level (OR = 1.306, p = 0.044), Victivallales at the order level (OR = 1.306, p = 0.044), Mollicutes at the order level (OR = 1.424, p = 0.041), and Faecalibacterium at the genus level (OR = 1.763, p = 0.002) are associated with a higher risk of MG. - **Microbiota Decreasing Risk**: Actinobacteria at the phylum level (OR = 0.602, p = 0.0124), Gammaproteobacteria at the class level (OR = 0.587, p = 0.036), Defluviitaleaceae at the family level (OR = 0.695, p = 0.047), Peptococcaceae at the family level (OR = 0.698, p = 0.029), and Family XIII at the family level (OR = 0.614, p = 0.017) are associated with a lower risk of MG. ### Significance of the Study This study provides genetic evidence indicating a causal relationship between specific gut microbiota and MG, revealing the role of the gut microbiome-neuromuscular junction axis in the pathogenesis of MG. It offers new insights for the diagnosis and treatment of MG. ### Limitations - The participants are primarily of European descent, with limited data from other ethnicities, which may affect the generalizability of the results. - The lowest classification level is genus, not reaching more refined classifications such as species or strain levels. - The study uses GWAS summary statistics rather than raw data, preventing subgroup analysis of early and late cases. - Further research is needed to clarify the underlying mechanisms of these associations. ### Conclusion This study reveals a causal relationship between the gut microbiome and Myasthenia Gravis, providing a basis for future drug development and treatment options.